Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this feasibility study is to examine the effect of resistance training on muscle strength, lean body mass, physical functioning, fatigue, and quality of life in head and neck cancer patients receiving radiation therapy.
| Condition | Intervention | Phase |
|---|---|---|
|
Head and Neck Cancer Pharyngeal Cancer Laryngeal Cancer |
Behavioral: Nutrition Counseling Behavioral: Resistance Training |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Supportive Care |
| Official Title: | Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer |
- Number of head and neck cancer patients recruited to participate [ Time Frame: up to 16 months ] [ Designated as safety issue: No ]to test the feasibility of a randomized controlled exercise trial in head and neck cancer patients receiving radiation therapy
- change in muscle strength [ Time Frame: baseline, week 6, and week 12 ] [ Designated as safety issue: No ]dynamometer measurement
- Number of patients who adhere to cohort activity schedule [ Time Frame: baseline, week 6, and week 12 ] [ Designated as safety issue: No ]completion of exercise or diet recommendations
- change in lean body mass [ Time Frame: baseline, week 6, week 12 ] [ Designated as safety issue: No ]bioelectrical impedence
- change in physical functioning [ Time Frame: baseline, week 6, week 12 ] [ Designated as safety issue: No ]physical performance by doing a semi-tandem, tandem, or side by side stance with the feet, an 8 foot walk time, and 5 chair rise and sits
- change in fatigue level [ Time Frame: baseline, week 6, week 12 ] [ Designated as safety issue: No ]13-item Functional Assessment of Cancer Therapy-Fatigue scale
- change in quality of life [ Time Frame: baseline, week 6, week 12 ] [ Designated as safety issue: No ]37-item Functional Assessment of Cancer Therapy-Head and Neck scale
| Estimated Enrollment: | 44 |
| Study Start Date: | January 2011 |
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Resistance Training
Patient will meet with an exercise specialist once per week for the first 6 weeks. Patients will receive guidance in a safe and appropriate exercise regimen based on specific medical history and preference. An exercise specialist will telephone weekly for consultation and support once per week for the final 6 weeks.
|
Behavioral: Resistance Training
Patient will meet with an exercise specialist once per week for the first 6 weeks. Patients will receive guidance in a safe and appropriate exercise regimen based on specific medical history and preference. An exercise specialist will telephone weekly for consultation and support once per week for the final 6 weeks.
Other Name: resistance training
|
|
Nutrition Counseling
Patients will meet once per week with dietitian for the first 6 weeks in 60 minute sessions. Dietitian will telephone each patient weekly for the final 6 weeks of counseling and support.
|
Behavioral: Nutrition Counseling
Patients will meet once per week with dietitian for the first 6 weeks in 60 minute sessions. Dietitian will telephone each patient weekly for the final 6 weeks of counseling and support.
Other Name: nutrition
|
Detailed Description:
Head and neck cancer (HNCa) patients often lose significant body weight and lean mass which is associated with higher mortality, greater fatigue, poorer quality of life, and reduced physical functioning. Because nutritional supplementation may not consistently improve lean body mass, resistance training may be beneficial. HNCa patients experience unique side effects that impact nutritional status, limiting generalization of exercise intervention study results in other cancer types to HNCa patients. Therefore, 44 HNCa patients will be enrolled in a randomized controlled trial with the following study aims:
Primary study aim: Because this pilot proposal is among the first to attempt a randomized controlled exercise trial in HNCa patients, the primary study aim examines feasibility (e.g., study acceptance, recruitment, intervention process evaluation, adherence, adverse events, retention). The investigators hypothesize that study procedures will require minor alterations in future studies.
Secondary study aim #1: Because effect sizes are necessary for planning efficacy trials, the proposal will compare the effect of a 12-week resistance training plus nutritional counseling intervention versus nutritional counseling alone on muscle strength, lean body mass, physical functioning, fatigue, and quality of life in HNCa patients receiving radiation with or without chemotherapy. The investigators hypothesize that patients receiving resistance training with nutritional counseling will demonstrate greater improvements in the outcomes when compared with participants receiving nutritional counseling alone.
Secondary study aim #2: To enhance adherence in future intervention trials, this proposal will determine resistance training and nutritional adherence rates and associated factors among HNCa patients using attendance records, exercise logs, diet records, self-administered survey, and medical record review. The investigators hypothesize that adherence rates will be lower than that of other cancer populations with correlates including demographic, medical, and psychosocial factors.
Assessments will occur at baseline (first week of radiation), week 6 (mid-intervention), and week 12 (post-intervention). Qualitative and quantitative (e.g., rates, 95% confidence intervals) will assess feasibility and mixed model ANOVA will examine group differences. This information is critical for the design of future resistance training efficacy trials in HNCa patients to prevent lean body mass loss in HNCa patients, potentially reducing mortality, minimizing fatigue, and improving physical functioning and quality of life.
Eligibility| Ages Eligible for Study: | 19 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion criteria:
- 1st time diagnosis of head and neck cancer (stage I, II, III, or IV pharyngeal or laryngeal)
- age 19 to 75 years old
- English speaking
- radiation therapy planned or underway < 1 week
- Karnofsky performance status ≥ 60%, and
- able to stand
Exclusion Criteria:
- dementia or organic brain syndrome
- severe emotional distress
- active schizophrenia
- quadriplegia or loss of use of limbs or torso
- tendon rupture
- muscle tear
- another diagnoses of cancer in the past 5 years, and
- oncologist refuses to allow screening for possible study participation
Contacts and Locations| Contact: Amanda Fogleman, B.S. | 205-975-1247 | afoglema@uab.edu |
| United States, Alabama | |
| University of Alabama at Birmingham | Recruiting |
| Birmingham, Alabama, United States, 35294 | |
| Principal Investigator: Laura Q. Rogers, MD, MPH | |
| Principal Investigator: | Laura Q Rogers, MD, MPH | University of Alabama at Birmingham |
More Information
Publications:
| Responsible Party: | Laura Q. Rogers, MD, MPH, Professor, University of Alabama at Birmingham |
| ClinicalTrials.gov Identifier: | NCT00827164 History of Changes |
| Other Study ID Numbers: | ROG-SCCI 09-001-1, UAB IRB X121218021 |
| Study First Received: | January 21, 2009 |
| Last Updated: | February 20, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Alabama at Birmingham:
|
head and neck cancer resistance training nutrition counseling radiation therapy pharyngeal or laryngeal cancer |
Additional relevant MeSH terms:
|
Laryngeal Neoplasms Head and Neck Neoplasms Pharyngeal Neoplasms Otorhinolaryngologic Neoplasms Neoplasms by Site Neoplasms |
Laryngeal Diseases Respiratory Tract Diseases Respiratory Tract Neoplasms Otorhinolaryngologic Diseases Pharyngeal Diseases Stomatognathic Diseases |
ClinicalTrials.gov processed this record on June 18, 2013